Ensuring Targeting of Lipid Nanoparticles is Crucial for Drug Safety

Trillions of dollars could be invested to ensure the production of patentable drugs in the future. However, a critical safety flaw lies in the lack of targeting for lipid nanoparticles used in drug delivery. Without proper targeting, these nanoparticles can be taken up by any cell they encounter in a haphazard manner throughout the body, having risks outside of the intended injection site. Understanding the natural development of immunity is crucial in addressing this issue.